Computational analysis identifies IGFBP7 and CDKN1A as a robust marker pair for senescent fibroblast subpopulations.

The senescence-associated secretory phenotype (SASP) is a critical hallmark of senescent cells, driving the progression of numerous age-related diseases, including cancer, cardiovascular disorders, and neurodegenerative diseases. Within the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) are highly heterogeneous stromal cells, making their precise identification challenging due to the lack of specific single markers. Understanding and targeting these diverse senescent fibroblast populations is crucial for therapeutic interventions.

This study employed an ensemble of time-evolving SASP gene sets to computationally characterize the heterogeneity of the senescence-associated secretory phenotype in fibroblast subpopulations. Researchers analyzed gene expression data across various tissues to identify robust markers capable of distinguishing different senescent fibroblast types. The methodology focused on identifying gene pairs that consistently co-expressed within these diverse senescent cell populations, aiming to overcome the limitations of single-marker identification.

The primary finding was the identification of IGFBP7 and CDKN1A as a potential robust marker pair for senescent fibroblast subpopulations. This pair consistently emerged from the analysis of SASP gene sets, suggesting their utility in distinguishing heterogeneous senescent cell types across different tissue contexts.

The study highlights IGFBP7 and CDKN1A as key candidates for improved identification of diverse senescent fibroblast populations, addressing a critical gap in current senescence research. While specific quantitative metrics like fold-changes or p-values were not detailed in the abstract, the consistent identification of this marker pair across various analyses underscores its significance. This suggests a more precise way to characterize the complex SASP profile in different senescent fibroblast subsets, moving beyond broad definitions of senescence.